Decentralization science project GenomesDAO has attracted follow

GenomesDAO is a project focused on Decentralization in the field of (DeSci), which has recently garnered attention from some well-known investment institutions. The project aims to reshape the financing, collaboration, and intellectual property protection methods of research projects through blockchain technology.

DeSci, as an emerging field, aims to utilize the Web3 technology stack to build public infrastructure that supports scientific research in a more fair and just manner. Although DeSci has already attracted the attention of some large institutions and well-known figures in the industry, its recognition among cryptocurrency users is still relatively low. However, considering the potential of DeSci to innovate research methods, this field may see significant development in the future.

GenomesDAO was established in 2018 and is one of the early projects in the DeSci field. As a biotechnology DAO, it provides a secure, decentralized, and incentivized genomic testing platform. In the current context where genomic data privacy is a major concern, the emergence of GenomesDAO is particularly significant.

The core concept of the platform is to return the ownership and control of genomic testing data to the users. Unlike traditional models, GenomesDAO allows users to manage their data in their "on-chain vault" and profit from it. This model combines privacy protection, data sovereignty, and token incentives.

Users can obtain genetic testing services through the GenomesDAO platform, and the testing data will be uploaded to the DNA database, which only the user has access to. Third-party pharmaceutical companies can apply to use this DNA data using the platform's tokens, and users can decide whether to agree, receiving tokens as a reward upon agreement.

GenomesDAO has recently completed its blockchain migration and token update. The new platform token $GENOME is not only used for data trading but also serves as a DAO governance token, allowing holders to earn voting rights and token rewards through staking.

From an investment perspective, GenomesDAO has advantages such as practical products, revenue models, potential narratives, and ongoing development. Although the current trading volume and market capitalization are low, as the DeSci field develops, the project may attract more attention. The project team is working hard to collaborate with governments and pharmaceutical companies to create more data mining opportunities for DAO members and is trying to attract more Web2 users.

Although GenomesDAO may present investment opportunities, investors should still carefully assess the risks and closely follow the overall development trends in the DeSci field.